- Earnings Miss, Strong Revenue: Hims & Hers reported an earnings per share (EPS) miss (-$0.10 vs. -$0.05 estimate) but significantly surpassed revenue expectations ($753.21 million vs. $698.89 million estimate) for Q2 2026.
- Positive Revenue Outlook: Despite a quarterly loss, the telehealth company raised its annual revenue forecast to between $3.1 billion and $3.3 billion, indicating confidence in future growth within the digital health market.
- Financial Health Indicators: Key financial ratios include a trailing P/E ratio of -51.24, a price-to-sales (P/S) ratio of 2.75, a debt-to-equity ratio of 4.77, and a current ratio of 0.93, presenting a mixed financial health picture for Hims & Hers.
Hims & Hers Health, Inc. (NYSE: HIMS) is a telehealth company that provides healthcare services online. It offers access to medical consultations and personalized treatments for various conditions directly to consumers. Hims & Hers operates in a growing digital health market, focusing on making healthcare more accessible through its online platform.
On August 10, 2026, Hims & Hers reported its second-quarter financial results. The company announced an earnings per share (EPS) of -$0.10, which did not meet the analyst consensus estimate of -$0.05. This loss is reflected in its trailing price-to-earnings (P/E) ratio of -51.24, which indicates the company is not currently profitable.
Despite the earnings miss, revenue for the quarter was strong at $753.21 million, surpassing the analyst expectation of $698.89 million. As highlighted by Reuters, this growth is driven by a significant increase in subscribers and the expansion of its personalized healthcare services. The company’s price-to-sales (P/S) ratio is 2.75.
Following the strong revenue performance, Hims & Hers raised its annual revenue forecast. The company now expects between $3.1 billion and $3.3 billion, an increase from its previous projection. This updated outlook comes even as the company reported a second-quarter loss, as noted by The Wall Street Journal.
From a financial health perspective, Hims & Hers has a debt-to-equity ratio of 4.77, which suggests it relies on a significant amount of debt to finance its assets. Its current ratio is 0.93, meaning its short-term debts are slightly greater than its short-term assets, which can be a measure of a company’s ability to pay its immediate bills.
